Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?

By Teschke Rolf   Schulze Johannes   Eickhoff Axel   Danan Gaby  

International Journal of Molecular Sciences, Vol. 18, Iss. 4, 2017-04 ,pp. : 803-803

MDPI

Access to resources Recommend Favorite

Associations of Drug Lipophilicity and Extent of Metabolism with Drug-Induced Liver Injury

By McEuen Kristin   Borlak Jürgen   Tong Weida   Chen Minjun  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-06 ,pp. : 1335-1335

MDPI

Access to resources Recommend Favorite

Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury

By Ortega-Alonso Aida   Stephens Camilla   Lucena M. Isabel   Andrade Raúl J.  

International Journal of Molecular Sciences, Vol. 17, Iss. 5, 2016-05 ,pp. : 714-714

MDPI

Access to resources Recommend Favorite

Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis

By Iorga Andrea   Dara Lily   Kaplowitz Neil  

International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-05 ,pp. : 1018-1018

MDPI

Access to resources Recommend Favorite

Molecular Research on Drug Induced Liver Injury

By Teschke Rolf   Danan Gaby  

International Journal of Molecular Sciences, Vol. 19, Iss. 1, 2018-01 ,pp. : 216-216

MDPI

Access to resources Recommend Favorite